Ratnakar Securities Pvt. Ltd.

RPG LIFE SCIENCES LTD.

NSE : RPGLIFEBSE : 532983ISIN CODE : INE105J01010Industry : Pharmaceuticals & DrugsHouse : RPG Enterprises

BSE2155.1515.6 (+0.73 %)

PREV CLOSE ( ) 2139.55

OPEN PRICE ( ) 2110.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 768

TODAY'S LOW / HIGH ( )2110.00 2164.15

52 WK LOW / HIGH ( )1446.75 2976.7

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 2007

Management Info

Harsh Goenka - Chairman Ashok Nair - Managing Director

Registered Office

Address R P G House , 463,Ceat Mahal,Dr. Annie Besant Road, Worli,
Mumbai,
Maharashtra-400030

Phone 022 - 24981650 / 24986375

Email info@rpglifesciences.com

Website www.rpglifesciences.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

29Apr Appointment of Director
Inter alia, approved:- 1. Recommended of final dividend of Rs. 20 (Rupe..

11Apr RPG Life Sciences informs about compli
RPG Life Sciences has enclosed certificate dated April 03, 2025 issued b..

08Apr RPG Life Sciences informs about change
RPG Life Sciences has informed that on the recommendation of the Nominat..

27Jan RPG Life Sciences leads the gainers of
RPG Life Sciences is currently trading at Rs. 2293.95, up by 216.55 poin..

25Jan RPG Life Sciences informs about newspa
In terms of the Regulation 30 read with Schedule III of the SEBI (Listin..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	1173.5	1832.4
Gross Profit	1349	2328.8
Operating Profit	305.5	1723.3
Net Sales	1430.9	6534.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE) 10035.75 (2.49%)	M.Cap ( in Cr)25089.38
Procter&Gamble Healt (BSE) 5689.95 (2.51%)	M.Cap ( in Cr)9444.97
Concord Biotech (BSE) 2013.45 (4.47%)	M.Cap ( in Cr)21063.95
Divi's Lab (BSE) 6626.15 (1.14%)	M.Cap ( in Cr)175903.46
Sanofi Cons. Health (BSE) 5124.20 (1.44%)	M.Cap ( in Cr)11801.35

Shareholding Pattern

	PROMOTERS	72.95%
	MUTUAL FUNDS/UTI	3.53%
	NON-INSTITUTION	21.47%
	FI/BANKS/INSURANCE	0.22%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quant Healthcare Fu...	9.28
Mirae Asset Multica...	1.26
Motilal Oswal Quant...	0.94
Union Small Cap Fun...	0.88
WOC Pharma and Heal...	0.84
Quant Active Fund(G)	0.43

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

RPG LIFE SCIENCES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES